Choosing the right embryo is one of the most critical decisions in IVF. At Panama Fertility, we combine advanced laboratory technology with artificial intelligence to support more accurate, data-driven embryo selection — helping increase the chances of a successful pregnancy while giving patients greater confidence throughout their journey.
What is Chloe AI?
Chloe AI is an advanced artificial intelligence system developed by Fairtility, designed to analyze embryo development using time-lapse data. It evaluates how embryos grow over time and helps identify those with the highest potential for a successful pregnancy.
Instead of relying only on visual observation, Chloe AI uses millions of data points from previous embryo development cycles to provide a more objective and data-driven assessment.
Why is FDA Clearance Important?
For international patients, especially those coming from the United States, this provides an additional layer of trust and confidence in the technology used during their treatment.
Clinical Results That Matter
- Up to 23% increase in ongoing pregnancy rates
- Up to 36% reduction in early miscarriage
- Up to 96% accuracy in embryo assessment support
How Panama Fertility Uses Chloe AI
At Panama Fertility, Chloe AI is fully integrated into our laboratory process. It works alongside our experienced embryologists, providing additional insights to support embryo selection — never replacing human expertise.
This combination of advanced technology and medical experience allows us to deliver a more precise, personalized, and reliable IVF process for every patient.
A Smarter, More Confident IVF Journey
By combining time-lapse monitoring with AI-powered analysis, we move from subjective observation to objective, data-driven decision-making. This means better embryo selection, improved outcomes, and greater peace of mind for patients.

